Table 1 All EYA4 variants found in this study.
From: Prevalence and clinical features of hearing loss caused by EYA4 variants
# | RefSeq ID | Nucleotide Change | Amino Acid Change | Exon | Domain | Genomic position (GRCh37.p5) | SIFT | PolyPhen2_HVIR | PolyPhen2_HVAR | LRT | Mut _Taster | Mut _Assessor | FATHMM | Meta SVM | Meta LR | CADD_Phred | Allele Frequency (Exac03) | Â | ACMG criteria (supporting evidence) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Likely causative | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||
1 | NM_004100 | c.222_223del | p.T74fs | 5 | V | 133769262 |  |  |  |  |  |  |  |  |  |  | 0 |  | Likely Pathogenic (PVS1 + PM2) |
2 | NM_004100 | c.498delG | p.Q166fs | 8 | V | 133783533 |  |  |  |  |  |  |  |  |  |  | 0 |  | Likely Pathogenic (PVS1 + PM2) |
3 | NM_004100 | c.517C > T | p.Q173X | 8 | V | 133783552 |  |  |  | 0.843 | 0.810 |  |  |  |  | 39.000 | 0 |  | Likely Pathogenic (PVS1 + PM2 + PP3) |
4 | NM_004100 | c.580 + 1G > A |  | intron 8 | V | 133783616 |  |  |  |  | 0.810 |  |  |  |  | 26.200 | 0 |  | Likely pathogenic(PVS1 + PM2 + PP3) |
5 | NM_004100 | c.910delC | p.P304fs | 11 | V | 133789809 |  |  |  |  |  |  |  |  |  |  | 0 |  | Likely Pathogenic (PVS1 + PM2) |
6 | NM_004100 | c.988C > T | p.Q330X | 12 | V | 133802618 |  |  |  | 0.843 | 0.810 |  |  |  |  | 47.000 | 0 |  | Likely Pathogenic (PVS1 + PM2 + PP3) |
7 | NM_004100 | c.1109G > C | p.R370P | 13 | E | 133804171 | 0.912 | 0.899 | 0.971 | 0.629 | 0.810 | 0.888 | 0.975 | 0.995 | 0.984 | 34.000 | 0 |  | VUS (PM2 + PP3) |
8 | NM_004100 | c.1177C > T | p.Q393X | 13 | E | 133804239 |  |  |  | 0.843 | 0.810 |  |  |  |  | 46.000 | 0.000008253 | 0.00009639(AFR) | Pathogenic (PVS1 + PS1 + PP3) |
9 | NM_004100 | c.1216G > C | p.G406R | 14 | E | 133827268 | 0.912 | 0.764 | 0.693 | 0.629 | 0.810 | 0.907 | 0.808 | 0.897 | 0.885 | 29.800 | 0 |  | VUS (PM2 + PP3) |
10 | NM_004100 | c.1663G > C | p.A555P | 18 | E | 133844240 | 0.784 | 0.899 | 0.916 | 0.843 | 0.810 | 0.865 | 0.975 | 0.989 | 0.985 | 32.000 | 0 |  | VUS (PM2 + PP3) |
11 | NM_004100 |  |  | CNV |  | 133782193–133789881 |  |  |  |  |  |  |  |  |  |  |  |  | Likely pathogenic (PVS1 + PM2) |
12 | NM_004100 |  |  | CNV |  | 133756417–133852199 |  |  |  |  |  |  |  |  |  |  |  |  | Likely pathogenic (PVS1 + PM2) |
Unlikely causative | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
13 | NM_004100 | c.278T > C | p.M93T | 6 | V | 133777694 | 0.153 | 0.090 | 0.127 | 0.305 | 0.810 | 0.065 | 0.623 | 0.514 | 0.500 | 14.76 * | 0 |  | VUS (PM2) |
14 | NM_004100 | c.887C > T | p.S296L | 11 | V | 133789786 | 0.721 | 0.548 | 0.533 | 0.629 | 0.537 | 0.741 | 0.853 | 0.816 | 0.812 | 23.600 | 0.00001651 ** | 0.0002(EAS) ** | VUS (PP3) |
15 | NM_004100 | c.936G > T | p.L312F | 11 | V | 133789835 | 0.491 | 0.764 | 0.764 | 0.843 | 0.810 | 0.805 | 0.862 | 0.800 | 0.842 | 23.000 | 0.00001651 ** | 0.0002(EAS) ** | VUS (PP3) |
16 | NM_004100 | c.995C > T | p.P332L | 12 | V | 133802625 | 0.348 | 0.764 | 0.739 | 0.843 | 0.810 | 0.684 | 0.953 | 0.970 | 0.972 | 27.900 | 0.000008264 ** | 0.0001(EAS) ** | VUS (PS1 + PP3) |
17 | NM_004100 | c.1790delT | p.V597fs | 19 | E | 133846343 |  |  |  |  |  |  |  |  |  |  | 0 |  | Pathogenic (PVS1 *** + PS1 + PM2) |
18 | NM_004100 | c.1886_1899del | p.A629fs | 20 | E | 133849909 |  |  |  |  |  |  |  |  |  |  | 0 |  | VUS (PVS1 *** + PM2) |